首页> 外国专利> Pharmaceutical compositions and medicaments for lightening skin or reducing the pigmentation of skin or for treating inflammatory disorder or dandruff in a human

Pharmaceutical compositions and medicaments for lightening skin or reducing the pigmentation of skin or for treating inflammatory disorder or dandruff in a human

机译:用于增白皮肤或减少皮肤色素沉着或治疗人的炎性疾病或头皮屑的药物组合物和药物

摘要

In the present invention, there is described a topical pharmaceutical composition for lightening skin or reducing the pigmentation of skin or inhibiting tyrosinase in a human, which composition comprises resorcinol of the general formula I or a pharmaceutically acceptable salt and pharmaceutically acceptable carrier thereof. Described is also a pharmaceutical composition intended for topical or transdermal administration for treating inflammatory disorder or dandruff in a human and containing the same active substance. Said inflammatory disorder can be represented especially by psoriasis, dermatitis or acne. There is also described the use of resorcinol of the general formula I or a pharmaceutically acceptable salt for the preparation of corresponding medicaments.
机译:在本发明中,描述了用于增白皮肤或减少人的皮肤色素沉着或抑制酪氨酸酶的局部药物组合物,该组合物包含通式I的间苯二酚或其药学上可接受的盐和药学上可接受的载体。还描述了旨在用于局部或透皮给药的药物组合物,其用于治疗人的炎症性疾病或头皮屑并且含有相同的活性物质。所述炎性疾病尤其可以表现为牛皮癣,皮炎或痤疮。还描述了通式I的间苯二酚或药学上可接受的盐在制备相应药物中的用途。

著录项

  • 公开/公告号CZ298939B6

    专利类型

  • 公开/公告日2008-03-19

    原文格式PDF

  • 申请/专利权人 PFIZER INC.;

    申请/专利号CZ20010003339

  • 发明设计人 COLLINGTON ERIC WILLIAM;

    申请日2000-03-14

  • 分类号A61K8/34;A61K9/06;A61K8/02;A61K8/03;A61K8/04;A61K8/14;A61K8/67;A61K9/08;A61K9/107;A61K31/015;A61K31/047;A61K31/05;A61K31/065;A61K31/19;A61K31/203;A61P17;A61P17/06;A61P17/10;A61P17/16;A61P29;A61P43;A61Q5;A61Q19/02;

  • 国家 CZ

  • 入库时间 2022-08-21 20:08:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号